Send the following on WhatsApp
Continue to ChatBetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001 https://www.nxtpsychedelics.com/news/articles/psychedelics/betterlife-announces-closing-of-1-168-million-convertible-debentures-to-further-advance-ind-enabling-studies-of-its-non-hallucinogenic-lsd-based-drug-candidate-betr-001/